Victor Calil

Victor Calil

Auto-generated profile, based on publicly available information

Victor Calil

Memory Clinic, D’Or Institute for Research and Education, Rio de Janeiro

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2020 in Dementia & Neuropsychologia
Verified
Journal Article
Open access
PDF file
VCVictor Calil
Victor Calil
EEEmma Elliott
Emma Elliott
WBWyllians Vendramini Borelli
Wyllians Vendramini Borelli
BBBreno José Alencar Pires Barbosa
Breno José Alencar Pires Barbosa
JBJessyka Bram
Jessyka Bram
PCPaulo Caramelli
Paulo Caramelli
In July 2019, a group of multidisciplinary dementia researchers from Brazil and the United Kingdom (UK) met in the city of Belo Horizonte, Minas Gerais, Brazil, to discuss and propose solutions to current challenges faced in the diagnosis, public perception and care of dementia. Here we summarize the outcomes from the workshop addressing challenges in diagnosis. Brazil faces a major problem in dementia underdiagnosis, particularly involving the population in an adverse socioeconomic context. There is poor availability of resources and specialists, and the knowledge of general practitioners and other healthcare professionals is far from satisfactory. Low education level is a further obstacle in diagnosing dementia, as the most commonly used screening tests are not designed to evaluate this population. Patients and their families must overcome the stigma of a diagnosis of dementia, which is still prevalent in Brazil and increases the burden of this condition. Whilst the UK has greater resources, dedicated memory services and a National Dementia Strategy plan, the National Health Service (NHS) has limited funding. Therefore, some challenges regarding diagnosis are common across both countries. The authors suggest possible solutions to confront these, with the goal of improving assessment and recognition of dementia and reducing misdiagnosis.

28 November 2022 in Dementia & Neuropsychologia
Verified
Journal Article
Open access
SBSonia Maria Dozzi Brucki
Sonia Maria Dozzi Brucki
IAIvan Aprahamian
Ivan Aprahamian
WBWyllians Vendramini Borelli
Wyllians Vendramini Borelli
VSVictor Calil da Silveira
Victor Calil da Silveira
CFCeres Eloah de Lucena Ferretti
Ceres Eloah de Lucena Ferretti
LMLilian Schafirovits Morillo
Lilian Schafirovits Morillo
RESUMO A doença de Alzheimer (DA) e outras demências neurodegenerativas têm um curso progressivo com comprometimento da cognição, capacidade funcional e comportamento. A maioria dos estudos enfocou a DA. A demência grave está associada ao aumento da idade, maior morbimortalidade e aumento dos custos de cuidados. É fundamental reconhecer que a demência grave é o período mais longo de progressão, com o paciente vivendo muitos anos nesta fase. É a fase mais heterogênea do processo, com diferentes habilidades e expectativa de vida. Esta diretriz de prática concentra-se na demência grave para melhorar o manejo e o cuidado nessa fase da demência. Como um longo período no continuum da demência, as abordagens não farmacológicas e farmacológicas devem ser consideradas. Intervenções multidisciplinares (fisioterapia, fonoaudiologia, nutrição, enfermagem, entre outras) são essenciais, além de educacionais e de apoio aos cuidadores.

17 February 2021 in International Journal of Geriatric Psychiatry
Verified
Journal Article
Closed access
PDF file
VCVictor Calil
Victor Calil
ASAndrea Silveira de Souza
Andrea Silveira de Souza
FSFelipe Kenji Sudo
Felipe Kenji Sudo
GSGustavo Santiago‐Bravo
Gustavo Santiago‐Bravo
NANaima Assunção
Naima Assunção
PMPaulo Mattos
Paulo Mattos

1 April 2021 in Arquivos de Neuro-Psiquiatria
Verified
Journal Article
Open access
VCVictor Calil
Victor Calil
FSFelipe Kenji Sudo
Felipe Kenji Sudo
GSGustavo Santiago-Bravo
Gustavo Santiago-Bravo
MLMarco Lima
Marco Lima
PMPaulo Mattos
Paulo Mattos
Background: Anosognosia, i.e. lack of awareness of one’s own symptoms, is a very common finding in patients with dementia and is related to neuropsychiatric symptoms and worse prognosis. Although dementia with Lewy bodies (DLB) is the second most common form of degenerative dementia, literature on anosognosia in this disease is scarce. Objectives: This paper aimed to review the current evidence on anosognosia in patients with DLB, including its prevalence in comparison with other neurological conditions, its severity and anatomical correlations. Methods: Database searches were performed in PubMed, Web of Knowledge and PsycINFO for articles assessing anosognosia in DLB. A total of 243 studies were retrieved, but only six were included in the review. Results: Potential risk of selection, comparison or outcome biases were detected in relation to all the studies selected. Most of the studies used self-report memory questionnaires to assess cognitive complaints and compared their results to scores from informant-based instruments or to participants’ cognitive performance in neuropsychological tasks. Subjects with DLB had worse awareness regarding memory than healthy older controls, but the results concerning differences in anosognosia between DLB and Alzheimer’s disease (AD) patients were inconsistent across studies. Presence of AD pathology and neuroimaging biomarkers appeared to increase the prevalence of anosognosia in individuals with DLB. Conclusion: Anosognosia is a common manifestation of DLB, but it is not clear how its prevalence and severity compare with AD. Co-existence of AD pathology seems to play a role in memory deficit awareness in DLB.

1 September 2022 in Dementia & Neuropsychologia
Verified
Journal Article
Open access
SBSonia Maria Dozzi Brucki
Sonia Maria Dozzi Brucki
IAIvan Aprahamian
Ivan Aprahamian
WBWyllians Vendramini Borelli
Wyllians Vendramini Borelli
VSVictor Calil da Silveira
Victor Calil da Silveira
CFCeres Eloah de Lucena Ferretti
Ceres Eloah de Lucena Ferretti
LMLilian Schafirovits Morillo
Lilian Schafirovits Morillo
Alzheimer’s disease (AD) and other neurodegenerative dementias have a progressive course, impairing cognition, functional capacity, and behavior. Most studies have focused on AD. Severe dementia is associated with increased age, higher morbidity-mortality, and rising costs of care. It is fundamental to recognize that severe dementia is the longest period of progression, with patients living for many years in this stage. It is the most heterogeneous phase in the process, with different abilities and life expectancies. This practice guideline focuses on severe dementia to improve management and care in this stage of dementia. As it is a long period in the continuum of dementia, clinical practice should consider non-pharmacological and pharmacological approaches. Multidisciplinary interventions (physical therapy, speech therapy, nutrition, nursing, and others) are essential, besides educational and support to caregivers.

18 March 2026 in Journal of Health Psychology
Verified
Journal Article
Closed access
CFClarissa Pacheco da Rocha Fernandes
Clarissa Pacheco da Rocha Fernandes
NONatalia Oliveira
Natalia Oliveira
RSRejane Soares
Rejane Soares
FRFernanda Rodrigues
Fernanda Rodrigues
GBGabriel Bernardes
Gabriel Bernardes
FSFelipe Kenji Sudo
Felipe Kenji Sudo
Depression is a frequent neuropsychiatric symptom in dementia, yet metabolic contributors remain poorly understood. Central adiposity may be involved, but conventional anthropometric measures may inadequately capture obesity in older adults. This cross-sectional study included 601 community-dwelling individuals aged 60–91 years evaluated at a memory clinic between 2015 and 2024. Dementia was diagnosed using DSM-5 criteria for Major Neurocognitive Disorder, and depressive symptoms were assessed with the 15-item Geriatric Depression Scale. Obesity was evaluated using multiple anthropometric indices, including Body Mass Index, Waist Circumference, Waist-to-Height Ratio, A Body Shape Index, Conicity Index, Weight-Adjusted Waist Index, and Body Roundness Index (BRI). No measure was associated with depression in the overall sample. Among individuals with dementia, higher BRI was associated with increased odds of depression, with those in the highest quartile showing more than threefold greater odds. These findings suggest that BRI may better capture central adiposity relevant to depression in dementia.